“Breakthrough” Dose-Finding In Oncology
This article was originally published in RPM Report
The “Breakthrough” era in oncology drug development creates new stress points in the effort to accelerate time-to-market. One important one involves the age-old challenge of finding the right dose – particularly in an era when the old idea of pushing the dose no longer makes sense.
Register for our free email digests: